The threat of antimicrobial resistance in developing countries: causes and control strategies
Abstract The causes of antimicrobial resistance (AMR) in developing countries are complex and may be rooted in practices of health care professionals and patients’ behavior towards the use of antimicrobials as well as supply chains of antimicrobials in the population. Some of these factors may inclu...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-05-01
|
Series: | Antimicrobial Resistance and Infection Control |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13756-017-0208-x |
_version_ | 1798045176616189952 |
---|---|
author | James A. Ayukekbong Michel Ntemgwa Andrew N. Atabe |
author_facet | James A. Ayukekbong Michel Ntemgwa Andrew N. Atabe |
author_sort | James A. Ayukekbong |
collection | DOAJ |
description | Abstract The causes of antimicrobial resistance (AMR) in developing countries are complex and may be rooted in practices of health care professionals and patients’ behavior towards the use of antimicrobials as well as supply chains of antimicrobials in the population. Some of these factors may include inappropriate prescription practices, inadequate patient education, limited diagnostic facilities, unauthorized sale of antimicrobials, lack of appropriate functioning drug regulatory mechanisms, and non-human use of antimicrobials such as in animal production. Considering that these factors in developing countries may vary from those in developed countries, intervention efforts in developing countries need to address the context and focus on the root causes specific to this part of the world. Here, we describe these health-seeking behaviors that lead to the threat of AMR and healthcare practices that drive the development of AMR in developing countries and we discuss alternatives for disease prevention as well as other treatment options worth exploring. |
first_indexed | 2024-04-11T23:16:27Z |
format | Article |
id | doaj.art-5026f37698074f1c956e12985343fdb0 |
institution | Directory Open Access Journal |
issn | 2047-2994 |
language | English |
last_indexed | 2024-04-11T23:16:27Z |
publishDate | 2017-05-01 |
publisher | BMC |
record_format | Article |
series | Antimicrobial Resistance and Infection Control |
spelling | doaj.art-5026f37698074f1c956e12985343fdb02022-12-22T03:57:35ZengBMCAntimicrobial Resistance and Infection Control2047-29942017-05-01611810.1186/s13756-017-0208-xThe threat of antimicrobial resistance in developing countries: causes and control strategiesJames A. Ayukekbong0Michel Ntemgwa1Andrew N. Atabe2Section for Clinical Microbiology, Redeem BiomedicalHuman Safety Division, Veterinary Drugs Directorate, Health Products and Food Branch, Health CanadaSchool of Epidemiology, Public Health and Preventive Medicine, Faculty of Medicine, University of OttawaAbstract The causes of antimicrobial resistance (AMR) in developing countries are complex and may be rooted in practices of health care professionals and patients’ behavior towards the use of antimicrobials as well as supply chains of antimicrobials in the population. Some of these factors may include inappropriate prescription practices, inadequate patient education, limited diagnostic facilities, unauthorized sale of antimicrobials, lack of appropriate functioning drug regulatory mechanisms, and non-human use of antimicrobials such as in animal production. Considering that these factors in developing countries may vary from those in developed countries, intervention efforts in developing countries need to address the context and focus on the root causes specific to this part of the world. Here, we describe these health-seeking behaviors that lead to the threat of AMR and healthcare practices that drive the development of AMR in developing countries and we discuss alternatives for disease prevention as well as other treatment options worth exploring.http://link.springer.com/article/10.1186/s13756-017-0208-xAntimicrobial therapyDeveloping countriesMicroorganismsResistance |
spellingShingle | James A. Ayukekbong Michel Ntemgwa Andrew N. Atabe The threat of antimicrobial resistance in developing countries: causes and control strategies Antimicrobial Resistance and Infection Control Antimicrobial therapy Developing countries Microorganisms Resistance |
title | The threat of antimicrobial resistance in developing countries: causes and control strategies |
title_full | The threat of antimicrobial resistance in developing countries: causes and control strategies |
title_fullStr | The threat of antimicrobial resistance in developing countries: causes and control strategies |
title_full_unstemmed | The threat of antimicrobial resistance in developing countries: causes and control strategies |
title_short | The threat of antimicrobial resistance in developing countries: causes and control strategies |
title_sort | threat of antimicrobial resistance in developing countries causes and control strategies |
topic | Antimicrobial therapy Developing countries Microorganisms Resistance |
url | http://link.springer.com/article/10.1186/s13756-017-0208-x |
work_keys_str_mv | AT jamesaayukekbong thethreatofantimicrobialresistanceindevelopingcountriescausesandcontrolstrategies AT michelntemgwa thethreatofantimicrobialresistanceindevelopingcountriescausesandcontrolstrategies AT andrewnatabe thethreatofantimicrobialresistanceindevelopingcountriescausesandcontrolstrategies AT jamesaayukekbong threatofantimicrobialresistanceindevelopingcountriescausesandcontrolstrategies AT michelntemgwa threatofantimicrobialresistanceindevelopingcountriescausesandcontrolstrategies AT andrewnatabe threatofantimicrobialresistanceindevelopingcountriescausesandcontrolstrategies |